Wave Life Sciences Ltd
Research Wave Life Sciences Ltd (WVE) on Bullrun: market cap USD 1.09B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerWVE
- ExchangeNASDAQ
- CountrySingapore
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.09B
- Financial periodFY2025
- RevenueUSD 42.73M
- Revenue growth-60.5%
- Net income-USD 204.38M
- Free cash flow-USD 188.21M
Valuation Snapshot
latest market cap is USD 1.09B.
About Wave Life Sciences Ltd
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders.
Frequently asked questions
What is Wave Life Sciences Ltd's market cap?
Wave Life Sciences Ltd's market capitalization is USD 1.09B.
What does Wave Life Sciences Ltd do?
Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.